TMDXTransMedics Group, Inc.
$77.81-36% 1Y
$77.81
$62.0452 weeks$150.42
TMDX in its own filings
Nothing in TMDX's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
133
Events found in the filings · across 627 filings · the record starts in 2018
- Hard flags
- none
Hard flags
- Most recent filing
- Sep 10, 2026
Most recent filing · Form 8-K
- Record starts
- Nov 16, 2018
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Oct 28, 2026
- SEC comment-letter activity11 occurrences
- 2020-05-19
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 10, 2026Transition of Chief Financial Officer On September 10, 2026, the Board of Directors (the “Board”) of TransMedics Group, Inc. (the “Company”) appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective as of September 21, 2026.Director or officer change · Form 8-K
- Aug 4, 2026TransMedics Reports Second Quarter 2026 Financial Results.Earnings release · press release
- May 5, 2026TransMedics Reports First Quarter 2026 Financial Results.Earnings release · press release
- Feb 27, 2026TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax.Earnings release · press release
- Feb 24, 2026TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
- Feb 4, 2026Transition of Chief Commercial Officer On February 1, 2026, the Board of Directors (the “Board”) of TransMedics Group, Inc. (the “Company”) appointed Giovanni Cecere as Chief Commercial Officer, effective as of February 2, 2026.Director or officer change · Form 8-K
- Jan 12, 2026On January 8, 2026, TransMedics Group, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with BioMed Realty (the “Landlord”) for the lease of approximately 498,286 square feet of space located at 188 Assembly Park Drive, Somerville, MA 02145 (the “Premises”) for the Company’s principal executive …Material agreement entered · Form 8-K
- Oct 29, 2025TransMedics Reports Third Quarter 2025 Financial Results.Earnings release · press release
- Oct 6, 2025As previously disclosed in a Current Report on Form 8-K filed by TransMedics Group, Inc. (the “Company”) on September 5, 2023, a Current Report on Form 8-K filed by the Company on September 12, 2023, a Current Report on Form 8-K filed by the Company on September 22, 2023, a Current Report on Form 8-K filed by the …Acquisition or disposition completed · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…